Pilulka Lekarny AS (XPRA:PINK) Other Current Receivables: Kč15 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:PINK Pilulka Lekarny AS XPRA:PINK
49 GF Score
Price Kč110.00
GF Value Kč111.77
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS Other Current Receivables?

Pilulka Lekarny AS XPRA:PINK +2.80% 49 Other Current Receivables is Kč15 Mil as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 49/100 and a GF Value™ of Kč111.77 (Fairly Valued). The stock has 6 warning signs investors should review.

Pilulka Lekarny AS's Other Current Receivables for the quarter that ended in Dec. 2025 was Kč15 Mil.

Pilulka Lekarny AS's quarterly Other Current Receivables increased from Jun. 2024 (Kč0.00 Mil) to Dec. 2024 (Kč9.69 Mil) and increased from Dec. 2024 (Kč9.69 Mil) to Dec. 2025 (Kč15.06 Mil).

Pilulka Lekarny AS's annual Other Current Receivables declined from Dec. 2023 (Kč37.31 Mil) to Dec. 2024 (Kč9.69 Mil) but then increased from Dec. 2024 (Kč9.69 Mil) to Dec. 2025 (Kč15.06 Mil).

Pilulka Lekarny AS Other Current Receivables Related Terms

Pilulka Lekarny AS Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS Other Current Receivables Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 0.00 52.05 37.31 9.69 15.06

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
Other Current Receivables Get a 7-Day Free Trial 52.05 37.31 0.00 9.69 15.06
XPRA:PINK
49GF Score
Pilulka Lekarny AS XPRA:PINK
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of Kč15 Mil mean?
Pilulka Lekarny AS (XPRA:PINK) has a Other Current Receivables of Kč15 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Pilulka Lekarny AS and its competitors.
Is Pilulka Lekarny AS's Other Current Receivables too high?
Pilulka Lekarny AS's current Other Current Receivables is Kč15 Mil. Overall, Pilulka Lekarny AS has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Other Current Receivables compare to competitors?
Pilulka Lekarny AS's Other Current Receivables of Kč15 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Pilulka Lekarny AS and its competitors. Pilulka Lekarny AS's current Other Current Receivables is Kč15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč111.77, compared to a current price of Kč110.00 — trading 1.6% below its estimated fair value. The current Other Current Receivables is Kč15 Mil. Pilulka Lekarny AS's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Other Current Receivables is Kč15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be undervalued. The current stock price of Kč110.00 is trading 1.6% below its estimated GF Value™ of Kč111.77. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • Other Current Receivables: Kč15 Mil
  • GF Value™: Kč111.77 vs. price of Kč110.00 (1.6% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
49GF Score

Get the complete analysis for XPRA:PINK

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč110.00
Price
Kč111.77
GF Value